The Institute of Endocrinology and Diabetes is one of the world’s leading clinical paediatric endocrinology research centres.
Led by Professor Kim Donaghue and Professor Geoff Ambler, our research staff leads basic and epidemiological studies into the causes of childhood diabetes and their complications. We also conduct clinical trials that aim to prevent or cure diabetes and osteoporosis in children.
The key theme of the research is prevention. The Institute’s ultimate objectives are to prevent the onset of type 1 and type 2 diabetes in children; to prevent the development of diabetes complications, and to prevent the morbidity, such as bone pain and fractures, in children with primary and secondary osteopenia.